Sabrina Schlienger Selected Research

ADP-Ribosylation Factor 1

3/2016	ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
1/2015	The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
1/2014	ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabrina Schlienger Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 03/2016 - 01/2014
3	Triple Negative Breast Neoplasms 03/2016 - 01/2015
2	Neoplasms (Cancer) 03/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

3	GTP Phosphohydrolases (GTPases)IBA 03/2016 - 01/2014
3	ADP-Ribosylation Factor 1IBA 03/2016 - 01/2014
2	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 03/2016 - 03/2015
2	GTP-Binding Proteins (G-Protein)IBA 03/2015 - 01/2014
2	Epidermal Growth Factor (EGF)IBA 01/2015 - 01/2014
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	Gefitinib (Iressa)FDA Link 01/2015
1	Monomeric GTP-Binding ProteinsIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2014

Therapy/Procedure

2	Therapeutics 03/2015 - 01/2015